Latest Update: Impact of current COVID-19 situation has been considered in this report while making the analysis.
Global Small Interfering RNA (siRNA) Therapeutics Market by Type (Liposome Based Systemic Therapy, Nanoparticle Based Systemic Therapy, Other), By Application (Hospital, Research Institutions, Pharmaceutical and Biotechnology Companies, Academic Institutions, Other) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030-report

Global Small Interfering RNA (siRNA) Therapeutics Market by Type (Liposome Based Systemic Therapy, Nanoparticle Based Systemic Therapy, Other), By Application (Hospital, Research Institutions, Pharmaceutical and Biotechnology Companies, Academic Institutions, Other) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030

Report ID: 168454 3300 Medical Devices & Consumables 377 249 Pages 4.6 (48)
                                          

The global small interfering RNA (siRNA) therapeutics market is expected to grow at a CAGR of 16.5% during the forecast period, from 2021 to 2030. The market is driven by factors such as increasing prevalence of chronic diseases and rising demand for personalized medicine. Liposome-based systemic therapy segment accounted for the largest share in the global siRNA therapeutics market in 2018, followed by nanoparticle-based systemic therapy segment. The liposome-based systemics therapy segment is expected to maintain its dominance throughout the forecast period owing to its ability to deliver siRNAs across cell membranes and into cells without degradation or interference from serum proteins or other cellular components. The hospital application segment accounted for the largest share in the global siRNA therapeutics market in 2018, followed by research institutions application segment. The hospital application segment is expected to maintain its dominance throughout the forecast period owing to high adoption rates of siRNAs among hospitals due their efficacy and safety profile which makes them suitable for use on patients with chronic diseases such as cancer, diabetes mellitus type 2, cardiovascular disease etc,.

Industry Growth Insights published a new data on “Small Interfering RNA (siRNA) Therapeutics Market”. The research report is titled “Small Interfering RNA (siRNA) Therapeutics Market research by Types (Liposome Based Systemic Therapy, Nanoparticle Based Systemic Therapy, Other), By Applications (Hospital, Research Institutions, Pharmaceutical and Biotechnology Companies, Academic Institutions, Other), By Players/Companies GE, Horizon Discovery, Thermo Scientific, OPKO Health, AInylam Pharmaceuticals, Arrowhead Research, Sanofi Genzyme, Genecon Biotechnologies, Arbutus Biopharma, Silent Therapeutics, Sylentis”.

Scope Of The Report

Report Attributes

Report Details

Report Title

Small Interfering RNA (siRNA) Therapeutics Market Research Report

By Type

Liposome Based Systemic Therapy, Nanoparticle Based Systemic Therapy, Other

By Application

Hospital, Research Institutions, Pharmaceutical and Biotechnology Companies, Academic Institutions, Other

By Companies

GE, Horizon Discovery, Thermo Scientific, OPKO Health, AInylam Pharmaceuticals, Arrowhead Research, Sanofi Genzyme, Genecon Biotechnologies, Arbutus Biopharma, Silent Therapeutics, Sylentis

Regions Covered

North America, Europe, APAC, Latin America, MEA

Base Year

2021

Historical Year

2019 to 2020 (Data from 2010 can be provided as per availability)

Forecast Year

2030

Number of Pages

249

Number of Tables & Figures

175

Customization Available

Yes, the report can be customized as per your need.


Global Small Interfering RNA (siRNA) Therapeutics Industry Outlook


Global Small Interfering RNA (siRNA) Therapeutics Market Report Segments:

The global Small Interfering RNA (siRNA) Therapeutics market is segmented on the basis of:

Types

Liposome Based Systemic Therapy, Nanoparticle Based Systemic Therapy, Other

The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.

Applications

Hospital, Research Institutions, Pharmaceutical and Biotechnology Companies, Academic Institutions, Other

The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.

Some of the companies that are profiled in this report are:

  1. GE
  2. Horizon Discovery
  3. Thermo Scientific
  4. OPKO Health
  5. AInylam Pharmaceuticals
  6. Arrowhead Research
  7. Sanofi Genzyme
  8. Genecon Biotechnologies
  9. Arbutus Biopharma
  10. Silent Therapeutics
  11. Sylentis

Global Small Interfering RNA (siRNA) Therapeutics Market Overview


Highlights of The Small Interfering RNA (siRNA) Therapeutics Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2030.
  5. Developments and trends in the market.
  6. By Type:

    1. Liposome Based Systemic Therapy
    2. Nanoparticle Based Systemic Therapy
    3. Other
  1. By Application:

    1. Hospital
    2. Research Institutions
    3. Pharmaceutical and Biotechnology Companies
    4. Academic Institutions
    5. Other
  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Small Interfering RNA (siRNA) Therapeutics Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.

Regional Analysis

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America

Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.

The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.

How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Global Small Interfering RNA (siRNA) Therapeutics Market Statistics

8 Reasons to Buy This Report

  1. Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
  2. Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
  3. Implemented Robust Methodology to Prepare the Report
  4. Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
  5. Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
  6. Provides Information About the Top-winning Strategies Implemented by Industry Players.
  7. In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
  8. Customization of the Report Available

Frequently Asked Questions?


Small interfering RNA (siRNA) therapeutics are a type of drug that use small pieces of RNA to interfere with the function of specific genes. This can be done in two ways: by directly targeting the gene, or by preventing the gene from being translated into protein. siRNA therapy is often used to treat diseases such as cancer, and has been shown to be effective in treating a variety of conditions including Alzheimeru2019s disease and Crohnu2019s disease.

Some of the major companies in the small interfering rna (sirna) therapeutics market are GE, Horizon Discovery, Thermo Scientific, OPKO Health, AInylam Pharmaceuticals, Arrowhead Research, Sanofi Genzyme, Genecon Biotechnologies, Arbutus Biopharma, Silent Therapeutics, Sylentis.

The small interfering rna (sirna) therapeutics market is expected to register a CAGR of 16.5%.

                                            
1. Executive Summary

2. Assumptions and Acronyms Used

3. Research Methodology

4. Small Interfering RNA (siRNA) Therapeutics Market Overview
   4.1. Introduction
      4.1.1. Market Taxonomy
      4.1.2. Market Definition
   4.2. Macro-Economic Factors
      4.2.1. Industry Outlook
   4.3. Small Interfering RNA (siRNA) Therapeutics Market Dynamics
      4.3.1. Market Drivers
      4.3.2. Market Restraints
      4.3.3. Opportunity
      4.3.4. Market Trends
   4.4. Small Interfering RNA (siRNA) Therapeutics Market - Supply Chain
   4.5. Global Small Interfering RNA (siRNA) Therapeutics Market Forecast
      4.5.1. Small Interfering RNA (siRNA) Therapeutics Market Size (US$ Mn) and Y-o-Y Growth
      4.5.2. Small Interfering RNA (siRNA) Therapeutics Market Size (000’ Units) and Y-o-Y Growth
      4.5.3. Small Interfering RNA (siRNA) Therapeutics Market Absolute $ Opportunity

5. Global Small Interfering RNA (siRNA) Therapeutics Market Analysis and Forecast by Type
   5.1. Market Trends
   5.2. Introduction
      5.2.1. Basis Point Share (BPS) Analysis by Type
      5.2.2. Y-o-Y Growth Projections by Type
   5.3. Small Interfering RNA (siRNA) Therapeutics Market Size and Volume Forecast by Type
      5.3.1. Liposome Based Systemic Therapy
      5.3.2. Nanoparticle Based Systemic Therapy
      5.3.3. Other
   5.4. Absolute $ Opportunity Assessment by Type
   5.5. Market Attractiveness/Growth Potential Analysis by Type

6. Global Small Interfering RNA (siRNA) Therapeutics Market Analysis and Forecast by Application
   6.1. Market Trends
   6.2. Introduction
      6.2.1. Basis Point Share (BPS) Analysis by Application
      6.2.2. Y-o-Y Growth Projections by Application
   6.3. Small Interfering RNA (siRNA) Therapeutics Market Size and Volume Forecast by Application
      6.3.1. Hospital
      6.3.2. Research Institutions
      6.3.3. Pharmaceutical and Biotechnology Companies
      6.3.4. Academic Institutions
      6.3.5. Other
   6.4. Absolute $ Opportunity Assessment by Application
   6.5. Market Attractiveness/Growth Potential Analysis by Application

7. Global Small Interfering RNA (siRNA) Therapeutics Market Analysis and Forecast by Sales Channel
   7.1. Market Trends
   7.2. Introduction
      7.2.1. Basis Point Share (BPS) Analysis by Sales Channel 
      7.2.2. Y-o-Y Growth Projections by Sales Channel
   7.3. Small Interfering RNA (siRNA) Therapeutics Market Size and Volume Forecast by Sales Channel 
      7.3.1. Manufacturer/Distributor/Service Provider
      7.3.2. Aftermarket
   7.4. Absolute $ Opportunity Assessment by Sales Channel
   7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel

8. Global Small Interfering RNA (siRNA) Therapeutics Market Analysis and Forecast by Region
   8.1. Market Trends
   8.2. Introduction
      8.2.1. Basis Point Share (BPS) Analysis by Region
      8.2.2. Y-o-Y Growth Projections by Region
   8.3. Small Interfering RNA (siRNA) Therapeutics Market Size and Volume Forecast by Region
      8.3.1. North America
      8.3.2. Latin America
      8.3.3. Europe
      8.3.4. Asia Pacific
      8.3.5. Middle East and Africa (MEA)
   8.4. Absolute $ Opportunity Assessment by Region
   8.5. Market Attractiveness/Growth Potential Analysis by Region
   8.6. Global Small Interfering RNA (siRNA) Therapeutics Demand Share Forecast, 2019-2026

9. North America Small Interfering RNA (siRNA) Therapeutics Market Analysis and Forecast
   9.1. Introduction
      9.1.1. Basis Point Share (BPS) Analysis by Country
      9.1.2. Y-o-Y Growth Projections by Country
   9.2. North America Small Interfering RNA (siRNA) Therapeutics Market Size and Volume Forecast by Country
      9.2.1. U.S.
      9.2.2. Canada
   9.3. Absolute $ Opportunity Assessment by Country
   9.4. North America Small Interfering RNA (siRNA) Therapeutics Market Size and Volume Forecast by Application
      9.4.1. Hospital
      9.4.2. Research Institutions
      9.4.3. Pharmaceutical and Biotechnology Companies
      9.4.4. Academic Institutions
      9.4.5. Other
   9.5. Basis Point Share (BPS) Analysis by Application
   9.6. Y-o-Y Growth Projections by Application
   9.7. North America Small Interfering RNA (siRNA) Therapeutics Market Size and Volume Forecast by Type
      9.7.1. Liposome Based Systemic Therapy
      9.7.2. Nanoparticle Based Systemic Therapy
      9.7.3. Other
   9.8. Basis Point Share (BPS) Analysis by Type
   9.9. Y-o-Y Growth Projections by Type
   9.10. Market Attractiveness/Growth Potential Analysis
      9.10.1. By Country
      9.10.2. By Product Type
      9.10.3. By Application
      9.10.4. By Sales Channel
   9.11. North America Small Interfering RNA (siRNA) Therapeutics Demand Share Forecast, 2019-2026

10. Latin America Small Interfering RNA (siRNA) Therapeutics Market Analysis and Forecast
   10.1. Introduction
      10.1.1. Basis Point Share (BPS) Analysis by Country
      10.1.2. Y-o-Y Growth Projections by Country
      10.1.3. Latin America Average Pricing Analysis
   10.2. Latin America Small Interfering RNA (siRNA) Therapeutics Market Size and Volume Forecast by Country
      10.2.1. Brazil
      10.2.2. Mexico
      10.2.3. Rest of Latin America
   10.3. Absolute $ Opportunity Assessment by Country
   10.4. Latin America Small Interfering RNA (siRNA) Therapeutics Market Size and Volume Forecast by Application
      10.4.1. Hospital
      10.4.2. Research Institutions
      10.4.3. Pharmaceutical and Biotechnology Companies
      10.4.4. Academic Institutions
      10.4.5. Other
   10.5. Basis Point Share (BPS) Analysis by Application
   10.6. Y-o-Y Growth Projections by Application
   10.7. Latin America Small Interfering RNA (siRNA) Therapeutics Market Size and Volume Forecast by Type
      10.7.1. Liposome Based Systemic Therapy
      10.7.2. Nanoparticle Based Systemic Therapy
      10.7.3. Other
   10.8. Basis Point Share (BPS) Analysis by Type
   10.9. Y-o-Y Growth Projections by Type
   10.10. Market Attractiveness/Growth Potential Analysis
      10.10.1. By Country
      10.10.2. By Product Type
      10.10.3. By Application
      10.10.4. By Sales Channel
   10.11. Latin America Small Interfering RNA (siRNA) Therapeutics Demand Share Forecast, 2019-2026

11. Europe Small Interfering RNA (siRNA) Therapeutics Market Analysis and Forecast
   11.1. Introduction
      11.1.1. Basis Point Share (BPS) Analysis by Country
      11.1.2. Y-o-Y Growth Projections by Country
      11.1.3. Europe Average Pricing Analysis
   11.2. Europe Small Interfering RNA (siRNA) Therapeutics Market Size and Volume Forecast by Country
      11.2.1. Germany
      11.2.2. France
      11.2.3. Italy
      11.2.4. U.K.
      11.2.5. Spain
      11.2.6. Russia
      11.2.7. Rest of Europe
   11.3. Absolute $ Opportunity Assessment by Country
   11.4. Europe Small Interfering RNA (siRNA) Therapeutics Market Size and Volume Forecast by Application
      11.4.1. Hospital
      11.4.2. Research Institutions
      11.4.3. Pharmaceutical and Biotechnology Companies
      11.4.4. Academic Institutions
      11.4.5. Other
   11.5. Basis Point Share (BPS) Analysis by Application
   11.6. Y-o-Y Growth Projections by Application
   11.7. Europ Small Interfering RNA (siRNA) Therapeutics Market Size and Volume Forecast by Type
      11.7.1. Liposome Based Systemic Therapy
      11.7.2. Nanoparticle Based Systemic Therapy
      11.7.3. Other
   11.8. Basis Point Share (BPS) Analysis by Type
   11.9. Y-o-Y Growth Projections by Type
   11.10. Market Attractiveness/Growth Potential Analysis
      11.10.1. By Country
      11.10.2. By Product Type
      11.10.3. By Application
      11.10.4. By Sales Channel
   11.11. Europe Small Interfering RNA (siRNA) Therapeutics Demand Share, 2019-2026

12. Asia Pacific Small Interfering RNA (siRNA) Therapeutics Market Analysis and Forecast
   12.1. Introduction
      12.1.1. Basis Point Share (BPS) Analysis by Country
      12.1.2. Y-o-Y Growth Projections by Country
      12.1.3. Asia Pacific Average Pricing Analysis
   12.2. Asia Pacific Small Interfering RNA (siRNA) Therapeutics Market Size and Volume Forecast by Country
      12.2.1. China
      12.2.2. Japan
      12.2.3. South Korea
      12.2.4. India
      12.2.5. Australia
      12.2.6. Rest of Asia Pacific (APAC)
   12.3. Absolute $ Opportunity Assessment by Country
   12.4. Asia Pacific Small Interfering RNA (siRNA) Therapeutics Market Size and Volume Forecast by Application
      12.4.1. Hospital
      12.4.2. Research Institutions
      12.4.3. Pharmaceutical and Biotechnology Companies
      12.4.4. Academic Institutions
      12.4.5. Other
   12.5. Basis Point Share (BPS) Analysis by Application
   12.6. Y-o-Y Growth Projections by Application
   12.7. Asia Pacific Small Interfering RNA (siRNA) Therapeutics Market Size and Volume Forecast by Type
      12.7.1. Liposome Based Systemic Therapy
      12.7.2. Nanoparticle Based Systemic Therapy
      12.7.3. Other
   12.8. Basis Point Share (BPS) Analysis by Type
   12.9. Y-o-Y Growth Projections by Type
   12.10. Market Attractiveness/Growth Potential Analysis
      12.10.1. By Country
      12.10.2. By Product Type
      12.10.3. By Application
      12.10.4. By Sales Channel
   12.11. Asia Pacific Small Interfering RNA (siRNA) Therapeutics Demand Share, 2019-2026

13. Middle East & Africa Small Interfering RNA (siRNA) Therapeutics Market Analysis and Forecast
   13.1. Introduction
      13.1.1. Basis Point Share (BPS) Analysis by Country
      13.1.2. Y-o-Y Growth Projections by Country
      13.1.3. Asia Pacific Average Pricing Analysis
   13.2. Middle East & Africa Small Interfering RNA (siRNA) Therapeutics Market Size and Volume Forecast by Country
      13.2.1. Saudi Arabia
      13.2.2. South Africa
      13.2.3. UAE
      13.2.4. Rest of Middle East & Africa (MEA)
   13.3. Absolute $ Opportunity Assessment by Country
   13.4. Middle East & Africa Small Interfering RNA (siRNA) Therapeutics Market Size and Volume Forecast by Application
      13.4.1. Hospital
      13.4.2. Research Institutions
      13.4.3. Pharmaceutical and Biotechnology Companies
      13.4.4. Academic Institutions
      13.4.5. Other
   13.5. Basis Point Share (BPS) Analysis by Application
   13.6. Y-o-Y Growth Projections by Application
   13.7. Middle East & Africa Small Interfering RNA (siRNA) Therapeutics Market Size and Volume Forecast by Type
      13.7.1. Liposome Based Systemic Therapy
      13.7.2. Nanoparticle Based Systemic Therapy
      13.7.3. Other
   13.8. Basis Point Share (BPS) Analysis by Type
   13.9. Y-o-Y Growth Projections by Type
   13.10. Market Attractiveness/Growth Potential Analysis
      13.10.1. By Country
      13.10.2. By Product Type
      13.10.3. By Application
      13.10.4. By Sales Channel
   13.11. Middle East & Africa Small Interfering RNA (siRNA) Therapeutics Demand Share, 2019-2026

14. Competition Landscape
   14.1. Global Small Interfering RNA (siRNA) Therapeutics Market: Market Share Analysis
   14.2. Small Interfering RNA (siRNA) Therapeutics Distributors and Customers
   14.3. Small Interfering RNA (siRNA) Therapeutics Market: Competitive Dashboard
   14.4. Company Profiles (Details – Overview, Financials, Developments, Strategy) 
      14.4.1. GE
         14.4.1.1. Overview
         14.4.1.2. Financials
         14.4.1.3. Developments
         14.4.1.4. Strategic Outlook
      14.4.2. Horizon Discovery
         14.4.2.1. Overview
         14.4.2.2. Financials
         14.4.2.3. Developments
         14.4.2.4. Strategic Outlook
      14.4.3. Thermo Scientific
         14.4.3.1. Overview
         14.4.3.2. Financials
         14.4.3.3. Developments
         14.4.3.4. Strategic Outlook
      14.4.4. OPKO Health
         14.4.4.1. Overview
         14.4.4.2. Financials
         14.4.4.3. Developments
         14.4.4.4. Strategic Outlook
      14.4.5. AInylam Pharmaceuticals
         14.4.5.1. Overview
         14.4.5.2. Financials
         14.4.5.3. Developments
         14.4.5.4. Strategic Outlook
      14.4.6. Arrowhead Research
         14.4.6.1. Overview
         14.4.6.2. Financials
         14.4.6.3. Developments
         14.4.6.4. Strategic Outlook
      14.4.7. Sanofi Genzyme
         14.4.7.1. Overview
         14.4.7.2. Financials
         14.4.7.3. Developments
         14.4.7.4. Strategic Outlook
      14.4.8. Genecon Biotechnologies
         14.4.8.1. Overview
         14.4.8.2. Financials
         14.4.8.3. Developments
         14.4.8.4. Strategic Outlook
      14.4.9. Arbutus Biopharma
         14.4.9.1. Overview
         14.4.9.2. Financials
         14.4.9.3. Developments
         14.4.9.4. Strategic Outlook
      14.4.10. Silent Therapeutics
         14.4.10.1. Overview
         14.4.10.2. Financials
         14.4.10.3. Developments
         14.4.10.4. Strategic Outlook
      14.4.11. Sylentis
         14.4.11.1. Overview
         14.4.11.2. Financials
         14.4.11.3. Developments
         14.4.11.4. Strategic Outlook
      14.4.12. COMPANY 12
         14.4.12.1. Overview
         14.4.12.2. Financials
         14.4.12.3. Developments
         14.4.12.4. Strategic Outlook
      14.4.13. COMPANY 13
         14.4.13.1. Overview
         14.4.13.2. Financials
         14.4.13.3. Developments
         14.4.13.4. Strategic Outlook
      14.4.14. COMPANY 14
         14.4.14.1. Overview
         14.4.14.2. Financials
         14.4.14.3. Developments
         14.4.14.4. Strategic Outlook
      14.4.15. COMPANY 15
         14.4.15.1. Overview
         14.4.15.2. Financials
         14.4.15.3. Developments
         14.4.15.4. Strategic Outlook
      14.4.16. COMPANY 16
         14.4.16.1. Overview
         14.4.16.2. Financials
         14.4.16.3. Developments
         14.4.16.4. Strategic Outlook
      14.4.17. COMPANY 17
         14.4.17.1. Overview
         14.4.17.2. Financials
         14.4.17.3. Developments
         14.4.17.4. Strategic Outlook
      14.4.18. COMPANY 18
         14.4.18.1. Overview
         14.4.18.2. Financials
         14.4.18.3. Developments
         14.4.18.4. Strategic Outlook
      14.4.19. COMPANY 19
         14.4.19.1. Overview
         14.4.19.2. Financials
         14.4.19.3. Developments
         14.4.19.4. Strategic Outlook
      14.4.20. COMPANY 20
         14.4.20.1. Overview
         14.4.20.2. Financials
         14.4.20.3. Developments
         14.4.20.4. Strategic Outlook

Our Trusted Clients

Contact Us